Following Mercia‘s recent life sciences portfolio, three of Mercia’s portfolio CEOs talk about their businesses with Edison: John Burt, CEO of Medherant; John von Benecke, CEO of Locate Bio; and Dr Harry Lamble, CEO of Sense Biodetection. They discuss the support they have received as part of the Mercia family, how their businesses have progressed, how COVID-19 has accelerated change across the sector and also touch on the likely drivers of future growth.